Filter
330
Filtered Results: 330
Text search:
AmC
Featured
Recommendations
24
New Publications
70
Language
Document type
No document type
114
Studies & Reports
93
Guidelines
47
Manuals
22
Strategic & Response Plan
20
Fact sheets
16
Training Material
9
Situation Updates
4
Resource Platforms
3
Infographics
1
Videos
1
Countries / Regions
India
32
Latin America and the Carribbean
14
Global
12
Kenya
10
Colombia
7
Nigeria
7
Ethiopia
7
Burkina Faso
6
Africa
6
Uganda
6
Benin
5
Cameroon
5
West and Central Africa
5
Brazil
5
Senegal
4
Malawi
4
Tanzania
4
Germany
4
East and Southern Africa
4
Russia
4
Nepal
3
Haiti
3
Guinea-Bissau
3
Middle East and North Africa
3
Western and Central Europe
3
Bolivia
3
Bangladesh
3
Mali
3
Chad
3
Zambia
3
Indonesia
3
Tajikistan
2
Ukraine
2
Ghana
2
Zimbabwe
2
Philippines
2
Mozambique
2
Eastern Europe and Central Asia
2
Paraguay
2
Gabon
2
Central African Republic
2
Angola
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Serbia
1
Sierra Leone
1
China
1
Rwanda
1
Kazakhstan
1
Syria
1
Laos
1
Kyrgyzstan
1
Niger
1
Uzbekistan
1
Afghanistan
1
Peru
1
Mauritania
1
Guinea
1
Armenia
1
USA
1
Cambodia
1
Asia
1
Venezuela
1
Congo, Democratic Republic of
1
South–East Asia Region
1
North America
1
Turkmenistan
1
Belgium
1
Argentina
1
South Africa
1
Vietnam
1
Namibia
1
Sudan
1
Yemen
1
Georgia
1
Bhutan
1
South Sudan
1
Liberia
1
Ecuador
1
Myanmar / Burma
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
154
Key Resources
16
Clinical Guidelines
13
Public Health
11
Women & Child Health
7
Capacity Building
5
Pharmacy & Technologies
1
Toolboxes
AMR
58
COVID-19
49
NTDs
20
Planetary Health
16
Mental Health
13
TB
12
Pharmacy
12
Global Health Education
9
Health Financing Toolbox
8
NCDs
8
Caregiver
7
HIV
5
Rapid Response
3
Ebola & Marburg
3
Natural Hazards
2
Zika
2
Specific Hazards
1
Refugee
1
Disability
1
Cholera
1
Social Ethics
1
Conflict
1
2016-2018 Early implementation,
This report presents 2015 data on the consumption of systemic antibiotics from 65 countries and areas, contributing to our understanding of how antibiotics are used in these countries. In addition, the report documents early efforts of the World Health Organization (...
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
Has the world worked together to tackle the coronavirus? July 2021. This research paper assesses how the global community has responded to calls for greater solidarity in tackling the COVID-19 pandemic, and presents the insights of key stakeholders and experts in global health governance, health sec...
Guía de Práctica Clínica para el manejo de la hipertensión arterial primaria (HTA)
The Pocket Guide to Managing Contraceptive Supplies addresses one of
the most important components of any program that provides family
planning services—the logistics system that manages the delivery,
quality, and storage of contraceptive supplies. These supplies are
essential; without them, f...
You can also register into a free online course
https://www.open.edu/openlearncreate/course/view.php?id=13
Antibiotics use with care
El informe anual de la vigilancia de la resistencia a los antibióticos de los países participantes de la Región de las Américas se discute y analiza con el fin de tomar medidas para el perfeccionamiento continuo de la calidad de los datos, y su utilidad en la orientación a los clínicos para el...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...
The annual Development Co-operation Report brings new evidence, analysis and ideas on
sustainable development to members of the OECD Development Assistance Committee (DAC) and the international community more broadly. The objectives are to promote best practices and innovation in development co-ope...
The National Action Plan (NAP) has been developed based on the model recommended in the global Action Plan. Local data on on-going interventions were collected from technical informants in the various areas of work. These were analysed using the policy framework provided by the AMR policy document. ...
Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites
change over time and no longer respond to medicines, making infections harder or impossible to treat,
and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has...
The purpose of this publication is to to provide a practical, stepwise approach to the implementation of the national action plans on AMR within the human health sector; and to provide a process and collation of existing WHO tools to prioritize, cost, implement, monitor and evaluate national action ...
Mali national action plan on antimicrobial resistance: review of progress in the human health sector
This policy brief aims to provide a review of the current progress on implementing the Mali national action plan on AMR, identifies critical gaps, and highlights findings to accelerate further progress in the human health sector. The target audience includes all those concerned with implementing act...
In the last decade, Timor-Leste has made remarkable progress in strengthening its health system and improving the health status of its population. This has resulted in an increased life expectancy, and the achievement of Millennium Development Goals such as a reduction in infant and under-five morta...
Abstract: Chagas disease is caused by infection with the protozoan Trypanosoma cruzi, and although over 100 years have passed since the discovery of Chagas disease, it still presents an increasing problem for global public health. A plethora of information concerning the chronic phase of human Chaga...
